REQUEST A DEMO
Total
USD $0.00
Search more companies

Daana Phrma Company Public Joint Stock (Iran)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Daana Phrma Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Daana Pharmaceutical Company, as one of the biggest and most advanced pharmaceutical complexes in the region, has been established on the Hillside of mount Sahand and in the beautiful city of Tabriz. The company is one of the biggest pharmaceutical manufacturers of the dosage type of Injectable Vials, Soft Gelatin Capsules, Tablets, Capsules, Oral Suspensions and Sachets in the country. Manufacturing activities of the company are divided into two main parts - Antibiotics active ingredients (API) and finished dosage forms of pharmaceutical and food-supplement products pharmaceutical, to improve public health and quality of life, is active in domestic and foreign markets.

Legal Address
Ghaem Magham Farahani Street, Sixth Alley, No 3
Tehran; Tehran; Postal Code: 1586855613

Contact Details: Purchase the Daana Phrma Company Public Joint Stock report to view the information.

Website: http://www.daanapharma.com

Basic Information
Total Employees:
Purchase the Daana Phrma Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Daana Phrma Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Daana Phrma Company Public Joint Stock report to view the information.
Incorporation Date:
1990
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
35%
Purchase this report to view the information.
14%
Purchase this report to view the information.
2%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Daana Phrma Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
77.98%
Total operating revenue
77.98%
Operating profit (EBIT)
44.48%
EBITDA
45.49%
Net Profit (Loss) for the Period
37.43%
Total assets
55.25%
Total equity
34.63%
Operating Profit Margin (ROS)
-10.49%
Net Profit Margin
-8.73%
Return on Equity (ROE)
1.17%
Debt to Equity Ratio
26.35%
Quick Ratio
-0.07%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?